Page last updated: 2024-10-31

methylphenidate and Obesity, Morbid

methylphenidate has been researched along with Obesity, Morbid in 2 studies

Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.

Obesity, Morbid: The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2.

Research Excerpts

ExcerptRelevanceReference
" In this article, we report and analyze a case of 52-year-old male patient with morbid obesity and attention-deficit/hyperactivity disorder (ADHD) who experienced lack of methylphenidate efficacy after Roux en-Y gastric bypass (RYGB), which was eventually resolved by using the transdermal patch instead of an oral product."4.95Impaired oral absorption of methylphenidate after Roux-en-Y gastric bypass. ( Azran, C; Dahan, A; Langguth, P, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azran, C1
Langguth, P1
Dahan, A1
Ludvigsson, M1
Haenni, A1

Reviews

1 review available for methylphenidate and Obesity, Morbid

ArticleYear
Impaired oral absorption of methylphenidate after Roux-en-Y gastric bypass.
    Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 2017, Volume: 13, Issue:7

    Topics: Administration, Oral; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulan

2017

Other Studies

1 other study available for methylphenidate and Obesity, Morbid

ArticleYear
Methylphenidate toxicity after Roux-en-Y gastric bypass.
    Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 2016, Volume: 12, Issue:5

    Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Diabetes Me

2016